Department of Emergency Medicine

October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

By Bill Snyder
Emergency medical staff practice pediatric life support techniques at Georgetown Public Hospital in Georgetown, Guyana. (photo taken prior to social distancing)
October 8, 2020

Nurse-led training program in Guyana carries on

Just weeks before the COVID-19 pandemic suspended international travel, Vanderbilt University Medical Center nurses completed two new educational initiatives in the South American country of Guyana, and a strong collaboration continues virtually in response to the coronavirus.

By Matt Batcheldor
October 5, 2020

Treating appendicitis with antibiotics instead of surgery may be good option for some, but not all, patients

Antibiotics instead of surgery may be a good choice for some, but not all, patients with appendicitis, according to results from a study reported today in the New England Journal of Medicine.

By Nancy Humphrey
September 17, 2020

Study finds COVID-19 antibodies drop substantially in the weeks following infection

The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).

By Nancy Humphrey
September 11, 2020

Study shows eating at restaurants may increase COVID-19 risk

Eating at dine-in restaurants appears to increase the risk of becoming sick with COVID-19, according to a recent study by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University Medical Center.

By Nancy Humphrey
September 3, 2020

COVID infections in health workers often go undetected: study

Many COVID-19 infections among health care workers go undetected, likely because many people infected with SARS-CoV-2, the virus that causes COVID-19, have mild or no symptoms, a study led by Vanderbilt University Medical Center’s Wesley Self, MD, MPH, shows.

By Nancy Humphrey
August 21, 2020

VUMC awarded $34 million to lead nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
By Bill Snyder
July 22, 2020

Study to explore how COVID affects cognition over time

The Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University Medical Center is following patients who have been hospitalized for COVID-19 over time to see if they develop long-term cognitive impairment, depression or post-traumatic stress disorder (PTSD).
By Nancy Humphrey
July 22, 2020

LifeFlight adds NPs, physicians to expand flight crew

Patients treated and transported by Vanderbilt LifeFlight are now receiving a higher level of care thanks to the credentialing of more than 20 flight nurses as nurse practitioners and the addition of a flight physician at several LifeFlight bases.
By Jerry Jones
July 16, 2020

Investments advance emergency medicine services at Vanderbilt Wilson County Hospital

On July 16, Vanderbilt Wilson County Hospital’s (VWCH) Emergency Department transitioned to become part of Vanderbilt University Medical Center’s Department of Emergency Medicine. The VWCH Emergency Department was previously staffed through physicians from a contracted agency.
By Kelsey Herbers
July 16, 2020

Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients

Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
By VUMC News and Communications
July 9, 2020

About half of health care workers positive for COVID-19 by serology have no symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.
By VUMC News and Communications
June 21, 2020

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. 
By VUMC News and Communications
1 … 4 5 6 7 8 … 12